Original language | English |
---|---|
Pages (from-to) | S23-S23 |
Journal | European journal of clinical pharmacology |
Volume | 78 |
Issue number | SUPPL 1 |
Publication status | Published - Jun 2022 |
Pharmacokinetics and Pharmacodynamics for Optimal Drug Repurposing of Imatinib from Cancer to COVID-19
N. Baalbaki, J. Aman, P. Bet, E. Duijvelaar, J. Twisk, C. Longo, K. Mahmoud, A. Maitland-van der Zee, H. Bogaard, E. Swart
- Pulmonary medicine (VUmc)
- Clinical pharmacology and pharmacy (VUmc)
- ACS - Pulmonary hypertension & thrombosis (VUmc)
- ACS - Microcirculation (VUmc)
- APH - Mental Health (VUmc)
- APH - Personalized Medicine (VUmc)
- Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep (VUmc)
- Epidemiology and Data Science (VUmc)
- APH - Health Behaviors & Chronic Diseases (VUmc)
- APH - Methodology (VUmc)
- CCA - Treatment and quality of life (VUmc)
- CCA - Cancer biology and immunology (VUmc)
- CCA - Imaging and biomarkers (VUmc)
Research output: Contribution to journal › Meeting Abstract › Academic